Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Intuitive Surg Inc (ISRG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 63,546,440
  • Shares Outstanding, K 113,750
  • Annual Sales, $ 3,129 M
  • Annual Income, $ 660,000 K
  • 36-Month Beta 0.86
  • Price/Sales 20.66
  • Price/Cash Flow 66.50
  • Price/Book 11.02

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate 2.24
  • Number of Estimates 2
  • High Estimate 2.32
  • Low Estimate 2.15
  • Prior Year 2.55
  • Growth Rate Est. (year over year) -12.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
518.82 +8.87%
on 08/20/18
572.96 -1.42%
on 09/14/18
+39.90 (+7.60%)
since 08/17/18
3-Month
467.98 +20.69%
on 06/25/18
572.96 -1.42%
on 09/14/18
+74.15 (+15.11%)
since 06/18/18
52-Week
337.80 +67.21%
on 09/26/17
572.96 -1.42%
on 09/14/18
+216.06 (+61.95%)
since 09/18/17

Most Recent Stories

More News
Here's Why You Should Invest in Masimo (MASI) Right Now

A raised guidance for 2018 and positive developments make Masimo (MASI) a lucrative choice for investors.

ATHN : 135.27 (-5.47%)
VEEV : 105.20 (+0.69%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
ResMed Unveils AirFit F30, Expands AirFit Mask Portfolio

ResMed's (RMD) recent product launches will strengthen its position in the high-potential sleep-disordered breathing market.

AMED : 120.10 (+0.51%)
RMD : 113.43 (+0.59%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
QIAGEN (QGEN) Partners DiaSorin to Extend QuantFERON Offers

Per QIAGEN (QGEN), the latest LIAISON QuantiFERON-TB Plus Test is likely to tackle the growing transformation of global latent TB testing market into the modern blood-based QuantiFERON technology.

AMED : 120.10 (+0.51%)
MASI : 123.09 (+1.72%)
QGEN : 38.12 (+1.87%)
ISRG : 564.82 (+1.10%)
Cooper's MiSight Lens Effective in Checking Juvenile Myopia

Cooper's (COO) core CVI business gets a boost from MiSight's positive study results.

COO : 264.76 (+1.96%)
ATHN : 135.27 (-5.47%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
Can Intuitive Surgical (ISRG) Keep the Earnings Surprise Streak Alive?

Intuitive Surgical (ISRG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

ISRG : 564.82 (+1.10%)
Here's Why You Should Add Abbott (ABT) to Your Portfolio Now

Abbott (ABT) continues to deliver strong and consistent performance in all segments. The company has also been hogging the limelight within Diabetic Care on progress with its FreeStyle Libre.

ABT : 68.41 (+1.09%)
AMED : 120.10 (+0.51%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
CVS Health (CVS) PBM Strengthens, Aetna Deal Shows Promise

A robust 2019 PBM selling season is a tailwind for CVS Health (CVS). Additionally, the company's milestone acquisition of Aetna might alter the whole healthcare landscape in the United States.

CVS : 78.61 (+0.65%)
RTIX : 4.35 (unch)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
QIAGEN Collaborates With NeuMoDx, Expands NGS Portfolio

QIAGEN (QGEN) forges ahead with deals to strengthen the NGS Platform.

AMED : 120.10 (+0.51%)
MASI : 123.09 (+1.72%)
QGEN : 38.12 (+1.87%)
ISRG : 564.82 (+1.10%)
DaVita Kidney Care Opens 150000-Square-Foot Campus in DeLand

DaVita's (DVA) dialysis care in the United States gets a boost; market prospects solid.

ATHN : 135.27 (-5.47%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)
DVA : 70.71 (+0.50%)
Omnicell Continues to Pursue Buyouts, Costs on the Rise

Omnicell (OMCL) progresses well with its strategy to grow inorganically. Rising operating expenses a concern.

OMCL : 68.95 (+0.15%)
AMED : 120.10 (+0.51%)
MASI : 123.09 (+1.72%)
ISRG : 564.82 (+1.10%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More Share

Trade ISRG with:

Business Summary

Intuitive Surgical, Inc. is the global technology leader in minimally invasive robotic-assisted surgery. The Company's da Vinci Surgical System enables surgeons to operate minimally invasively through a few small incisions or the belly button from a nearby ergonomic console. The da Vinci System features...

See More

Key Turning Points

2nd Resistance Point 572.60
1st Resistance Point 568.71
Last Price 564.82
1st Support Level 559.72
2nd Support Level 554.62

See More

52-Week High 572.96
Last Price 564.82
Fibonacci 61.8% 483.13
Fibonacci 50% 455.38
Fibonacci 38.2% 427.63
52-Week Low 337.80

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar